**In late August 2026, flu hospitalization rates remain at seasonal baseline levels, with CDC surveillance showing very low influenza activity nationally as of August 28.** Week 34 (roughly ending August 22–29) falls well outside the typical Northern Hemisphere flu season, when warmer temperatures, higher humidity, and reduced close-contact settings sharply limit transmission of influenza A and B viruses. Official FluSurv-NET and NHSN data indicate weekly rates hovered at 0.1 per 100,000 in June and have stayed low through summer, consistent with historical off-season patterns where sporadic cases produce minimal or zero measurable hospitalizations. **The tight market split around exactly 0.1 reflects genuine uncertainty in final reported figures rather than active circulation.** Small variations can arise from reporting delays, testing volumes, age-group weighting in surveillance networks, or isolated early detections, while overall positivity remains under 1% in clinical labs and respiratory illness activity is classified as “very low.” Traders weigh the strong precedent for rates at or below this threshold against the possibility of minor upward revisions in preliminary data. Upcoming weekly updates from CDC’s RESP-NET and FluView will provide the definitive numbers for market resolution.
基于Polymarket数据的AI实验性摘要。这不是交易建议,也不影响该市场的结算方式。 · 更新于2026年第34周流感住院率?
0.1 52%
<0.1 48%
>0.1 48%
<0.1
48%
0.1
52%
>0.1
48%
0.1 52%
<0.1 48%
>0.1 48%
<0.1
48%
0.1
52%
>0.1
48%
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
CDC FluView reports the weekly FluSurv-NET hospitalization rate per 100,000 population to one decimal point (e.g., 0.1). Thus, this is the level of precision that will be used when resolving the market.
Note: Only the CDC FluSurv-NET weekly hospitalization rate per 100,000 population for the specified week will qualify, regardless of the cumulative influenza-associated hospitalization rate, estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
市场开放时间: Aug 28, 2026, 11:04 AM ET
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
CDC FluView reports the weekly FluSurv-NET hospitalization rate per 100,000 population to one decimal point (e.g., 0.1). Thus, this is the level of precision that will be used when resolving the market.
Note: Only the CDC FluSurv-NET weekly hospitalization rate per 100,000 population for the specified week will qualify, regardless of the cumulative influenza-associated hospitalization rate, estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
**In late August 2026, flu hospitalization rates remain at seasonal baseline levels, with CDC surveillance showing very low influenza activity nationally as of August 28.** Week 34 (roughly ending August 22–29) falls well outside the typical Northern Hemisphere flu season, when warmer temperatures, higher humidity, and reduced close-contact settings sharply limit transmission of influenza A and B viruses. Official FluSurv-NET and NHSN data indicate weekly rates hovered at 0.1 per 100,000 in June and have stayed low through summer, consistent with historical off-season patterns where sporadic cases produce minimal or zero measurable hospitalizations. **The tight market split around exactly 0.1 reflects genuine uncertainty in final reported figures rather than active circulation.** Small variations can arise from reporting delays, testing volumes, age-group weighting in surveillance networks, or isolated early detections, while overall positivity remains under 1% in clinical labs and respiratory illness activity is classified as “very low.” Traders weigh the strong precedent for rates at or below this threshold against the possibility of minor upward revisions in preliminary data. Upcoming weekly updates from CDC’s RESP-NET and FluView will provide the definitive numbers for market resolution.
基于Polymarket数据的AI实验性摘要。这不是交易建议,也不影响该市场的结算方式。 · 更新于


警惕外部链接哦。
警惕外部链接哦。
常见问题